Calcium–MicroRNA Complex-Functionalized Nanotubular Implant Surface for Highly Efficient Transfection and Enhanced Osteogenesis of Mesenchymal Stem Cells
Source abstract
Abstract
Controlling mesenchymal stem cell (MSC) differentiation by RNA interference (RNAi) is a promising approach for next-generation regenerative medicine. However, efficient delivery of RNAi therapeutics is still a limiting factor. In this study, we have developed a simple, biocompatible, and highly effective delivery method of small RNA therapeutics into human MSCs (hMSCs) from an implant surface by calcium ions. First, we demonstrated that simple Ca/siRNA targeting green fluorescent protein (GFP) nanocomplexes were able to efficiently silence GFP in GFP-expressing hMSCs with adequate Ca2+ concentration (>5 mM). In addition, a single transfection could obtain a long-lasting silencing effect for more than 2 weeks. All three of the main endocytosis pathways (clathrin- and caveolin-mediated endocytosis and macropinocytosis) were involved in the internalization of the Ca/siRNA complexes by MSCs, and macropinocytosis plays the most dominant role. Furthermore, the Ca/siRNA complexes could be efficiently loaded onto the titanium implant surface when pretreated with anodization to create a nanotube (NT) layer. Because of the hydrophilic property of the NT surface, the Ca/siRNA was quickly loaded (less than 4 h) with high efficiency (nearly 100%), forming an even amorphous coating. The Ca/siRNA-coated NT surface showed an initial burst release of 80% of the siRNA complexes over 2 h, which is adequate to achieve robust gene silencing of attached hMSCs. To demonstrate the therapeutic potential of our Ca/siRNA coating technology, Ca/antimiR-138 complexes were loaded on to the NT surface, which strongly enhanced the osteogenic differentiation of hMSCs. In conclusion, our findings suggest that Ca2+ is an effective and biocompatible carrier to deliver small RNA therapeutics into hMSCs, both in solution and from functionalized surfaces, which provides a novel approach to control the MSC differentiation and tissue regeneration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China
Department of Clinical Medicine, Aarhus University, Aarhus 8200, Denmark
Funding
China Scholarship Council · National Natural Science Foundation of China · Lundbeckfonden
References (45)
Show source-provided references
1. 10.1128/mmbr.67.4.657-685.200310.1128/mmbr.67.4.657-685.2003 ↗
2. 10.1517/1471259090291142010.1517/14712590902911420 ↗
3. 10.1073/pnas.140174611110.1073/pnas.1401746111 ↗
4. 10.1016/j.jconrel.2007.07.01610.1016/j.jconrel.2007.07.016 ↗
5. 10.2217/nnm.13.20410.2217/nnm.13.204 ↗
6. 10.1016/j.jconrel.2015.02.02910.1016/j.jconrel.2015.02.029 ↗
7. 10.1016/j.cell.2007.11.02810.1016/j.cell.2007.11.028 ↗
8. 10.1007/s00068-014-0451-210.1007/s00068-014-0451-2 ↗
9. 10.1186/s12957-015-0694-310.1186/s12957-015-0694-3 ↗
10. 10.1177/002203451039396710.1177/0022034510393967 ↗
11. 10.1155/2012/98035310.1155/2012/980353 ↗
12. Hosseini S. · 2016
13. 10.1038/mt.2010.16610.1038/mt.2010.166 ↗
14. 10.1002/adfm.20130083210.1002/adfm.201300832 ↗
15. 10.1038/nm.261710.1038/nm.2617 ↗
16. 10.1038/ncomms1037610.1038/ncomms10376 ↗
17. 10.1073/pnas.101675810810.1073/pnas.1016758108 ↗
18. 10.1021/am400374c10.1021/am400374c ↗
19. 10.2147/IJN.S7651310.2147/IJN.S76513 ↗
20. 10.1007/978-1-60761-769-3_1210.1007/978-1-60761-769-3_12 ↗
21. 10.1007/s00216-010-3821-610.1007/s00216-010-3821-6 ↗
22. 10.1021/acsami.6b1655610.1021/acsami.6b16556 ↗
23. 10.1016/j.biomaterials.2014.04.06810.1016/j.biomaterials.2014.04.068 ↗
24. 10.1385/mb:30:1:00910.1385/mb:30:1:009 ↗
25. 10.1038/mtm.2014.5810.1038/mtm.2014.58 ↗
26. 10.1016/j.celrep.2012.04.01110.1016/j.celrep.2012.04.011 ↗
27. 10.1038/ncomms1128410.1038/ncomms11284 ↗
28. 10.1124/jpet.112.19721010.1124/jpet.112.197210 ↗
29. 10.1016/j.biomaterials.2011.04.06510.1016/j.biomaterials.2011.04.065 ↗
30. 10.1016/j.biomaterials.2011.10.03310.1016/j.biomaterials.2011.10.033 ↗
31. 10.1039/c4cc00181h10.1039/c4cc00181h ↗
32. 10.1016/j.ijpharm.2011.08.01210.1016/j.ijpharm.2011.08.012 ↗
33. 10.1039/c4tb01281j10.1039/c4tb01281j ↗
34. 10.1021/acsami.6b1169910.1021/acsami.6b11699 ↗
35. 10.1039/c5tb01062d10.1039/c5tb01062d ↗
36. 10.1021/nl201526210.1021/nl2015262 ↗
37. 10.1038/srep2306510.1038/srep23065 ↗
38. 10.1016/j.biomaterials.2014.08.02510.1016/j.biomaterials.2014.08.025 ↗
39. 10.1016/j.biomaterials.2012.10.02110.1016/j.biomaterials.2012.10.021 ↗
40. 10.1021/nn300106t10.1021/nn300106t ↗
41. 10.1002/adma.20130352010.1002/adma.201303520 ↗
42. 10.1038/mt.2010.16610.1038/mt.2010.166 ↗
43. 10.1016/j.biomaterials.2013.02.03910.1016/j.biomaterials.2013.02.039 ↗
44. 10.1359/jbmr.08110210.1359/jbmr.081102 ↗
45. 10.1371/journal.pone.015750410.1371/journal.pone.0157504 ↗